Fort, L.P. Bio Techne Corp Transaction History

Fort, L.P.

$38.5 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $206,648 - $284,869	-584 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$456.15 - $525.06 $783,665 - $902,053	-1,718 Reduced 74.63%	584 $302,000
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $653,069 - $791,075	-1,468 Reduced 38.94%	2,302 $1.12 Million
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $731,316 - $850,090	-1,888 Reduced 33.37%	3,770 $1.7 Million
Q1 2021 May 14, 2021	BUY	$314.62 - $411.0 $84,947 - $110,970	270 Added 5.01%	5,658 $2.16 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $590,091 - $769,269	2,390 Added 79.72%	5,388 $1.71 Million
Q3 2020 Nov 13, 2020	BUY	$232.22 - $282.96 $479,766 - $584,595	2,066 Added 221.67%	2,998 $743,000
Q2 2020 Aug 13, 2020	BUY	$185.43 - $279.56 $64,344 - $97,007	347 Added 59.32%	932 $246,000
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $94,284 - $129,583	585 New	585 $111,000
Q4 2019 Feb 13, 2020	SELL	$189.68 - $222.09 $420,710 - $492,595	-2,218 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$183.56 - $216.72 $916,515 - $1.08 Million	-4,993 Reduced 69.24%	2,218 $434,000
Q2 2019 Aug 13, 2019	SELL	$188.72 - $215.43 $247,600 - $282,644	-1,312 Reduced 15.39%	7,211 $1.5 Million
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $157,456 - $231,909	1,157 Added 15.71%	8,523 $1.69 Million
Q4 2018 Feb 13, 2019	BUY	$132.75 - $203.8 $229,657 - $352,574	1,730 Added 30.7%	7,366 $1.07 Million
Q3 2018 Nov 13, 2018	BUY	$147.44 - $204.11 $716,558 - $991,974	4,860 Added 626.29%	5,636 $1.15 Million
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $112,442 - $128,490	776 New	776 $115,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.62B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.

Account